http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105030669-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
filingDate | 2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105030669-B |
titleOfInvention | A kind of curcumin micelle eye drop and preparation method thereof |
abstract | The invention discloses a kind of curcumin micelle eye drop, it is main ingredient and preservative, isotonic regulator including curcumin, it is excipient substance characterized by further comprising Polyvinylcaprolactame polyvinyl acetate ethylene glycol copolymer, Dequalinium Chloride is Mitochondrially targeted dressing agent and stabilizer, and curcumin main ingredient and Polyvinylcaprolactame polyvinyl acetate the polyethyleneglycol block copolymer excipient substance mass ratio is 1:12‑1:Between 20, Dequalinium Chloride and Polyvinylcaprolactame polyvinyl acetate the ethylene glycol copolymer excipient substance mass ratio is 1:20‑1:Between 40.Curcumin micelle eye drop prepared by the present invention, administration concentration is up to 5mg/ml, and micella particle diameter is small, and distribution is homogeneous, and medicine stability is good.Administration excitant is not only reduced, absorption of the cornea to medicine is also improved, reduces administration concentration, the biddability extend drug treating time, reduce administration number of times, improving patient, there is good economy. |
priorityDate | 2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.